Recent Announcements

הודעה חשובה לבעלי מניות סלקט

June 14, 2017

Following the US, Cellect Receives Russian Patent Covering Any Device and Method Using Cellect's Flagship Technology - the ApoGraft™

 

June 12, 2017

Cellect Receives Notice of Allowance from the US Patent & Trademark Office

 

June 9, 2017

Cellect is Moving to Trade Exclusively on the NASDAQ

 

Jan 30, 2017

Dr. Yaron Pereg Appointed as New Chief Development Officer

Ex BioLineRx, Genentech Inc., Glusense and others

Jan 09, 2017

Major shareholder buying shares

Michael Ilan Management and Investment Ltd.increases holdings to 15.7%

Jan 01, 2017

Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer

Join our mailing list

© 2017 Cellect Biotherapeutics Ltd., all rights reserved

Submitting Form...

The server encountered an error.

Form received. Thank you.